medline.ch Gynäkologie Mammae

	Immunotherapy in the treatment of breast cancer. Magy Onkol Borbála S, Lajos P. PMID: 41385765 [PubMed - indexed for MEDLINE]
	Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial. JAMA Intern Med Fergus KB, Ross KS, Scheuner MT, Blanco AM, Tice JA, Ziv E, Shieh Y, van 't Veer L, Olopade OI, Goodman DL, Tong BS, Harvey H, DeRosa D, Risty L, Silver E, Kaster A, Fiscalini AS, Blum K, Heise R, Sabacan L, Heditsian D, Brain S, Petruse A, Eklund M, Hiatt RA, Borowsky AD, Naeim A, Park HL, LaCroix AZ, Parker BA, Lancaster R, Esserman J, Wenger N, Arasu V, Anton-Culver H, Esserman LJ, Madlensky L. PMID: 41385723 [PubMed - as supplied by publisher]
	Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast Cancer. Clin Cancer Res Martín M, Guerrero-Zotano AL, Pérez-López ME, Ruiz-Borrego M, Martinez Jañez N, Chacón JI, Gil-Gil M, Andrés R, Bermejo B, Sánchez-Rovira P, Del Barco S, Ponce JJ, Fernandez I, Martínez de Dueñas E, Hinojo-Gonzále C, González M, García-Garre E, Hernando B, de la Haba-Rodriguez J, Álvarez IM, González-Santiago S, Garcia-Saenz JA, Santaballa A, Casas M, Bezares S, Caballero R, Rojo F, Alba E. PMID: 41385615 [PubMed - as supplied by publisher]
	"This needs to be told to everyone": Content analysis of written immediate responses from an online experiment examining health warning messages about alcohol consumption and breast cancer risk. PLoS One Anbari A, Massey Z, Adediran A, Wang N, Lawrie L, Martinez P, McCarthy D. PMID: 41385524 [PubMed - indexed for MEDLINE]
	Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, LaCroix AZ, Borowsky AD, Anton-Culver H, Olopade OI, Esserman J, Lancaster R, Madlensky L, Blanco AM, Ross KS, Goodman DL, Tong BS, Hogarth M, Heditsian D, Brain S, Lee V, Blum K, Kim MO, Sabacan LP, Fergus KB, Yau C, Park HL, Parker BA, Kaplan C, Rhoads KF, Eder S, Adduci K, Matthews JB, Wenger NS, Shieh Y, Hiatt RA, Ziv E, Tice JA, Eklund M. PMID: 41385349 [PubMed - as supplied by publisher]
	Disparities in delays and outcomes in patients with HER2-positive breast cancer. Breast Cancer Res Treat Wooster M, DeStephano D, Beauchemin M, Wang S, Wright JD, Hur C, Hershman DL, Accordino MK. PMID: 41385136 [PubMed - indexed for MEDLINE]
	Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors. Breast Cancer Res Treat Ferri GM, Martinez CB, Acevedo J, Bhatt S, Verma KP, Lee J, Abdallah M, Szalat RE, Sloan JM. PMID: 41385110 [PubMed - indexed for MEDLINE]
	Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HRâ€‰+â€‰and HER2-negative breast cancer; a systematic review and meta-analysis. Breast Cancer Res Treat Sadia K, Talia T, Hussain I, Chaudhry M, Shahid N, Javaid MK, Kamil MF, Chaudry HZ, Azhar L, Khan HA, Ejaz A, Akram MU, Mahmood S, Abdul Qadeer M. PMID: 41385109 [PubMed - indexed for MEDLINE]
	Risk factors for postoperative bleeding following breast cancer surgery: a systematic review and meta-analysis. Breast Cancer Res Treat Yang Z, Qing M, Zhang Y, Wu J. PMID: 41385105 [PubMed - indexed for MEDLINE]
	Over-detection and over-surveillance in breast screening: current status and the potential for artificial intelligence optimisation. Insights Imaging Wang S, Liu J, Song L, Wen W, Huang J, Peng Y. PMID: 41385000 [PubMed]
	Diagnosing Breastfeeding Difficulties: Where Do We Stand? Matern Child Nutr Galante L, Kobayashi E, Nishikawa M. PMID: 41384455 [PubMed - indexed for MEDLINE]
	Long-Term Outcomes and Oncologic Implications of Histopathological Findings in Breast Reduction Specimens: A 15-Year Follow-Up Study. Aesthet Surg J Üstün GG, Ç, Yüceer ÖS, Da, Kösemehmeto, Uzun H. PMID: 41384364 [PubMed - as supplied by publisher]
	Pulmonary Benign Metastasizing Leiomyoma in a Patient With a Concurrent Breast Tumor: A Diagnostic Challenge. Cureus Araya T, Kita T, Higashi T, Hara R, Takato H. PMID: 41384190 [PubMed]
	Case Report: Difficulties in diagnosis of myeloid sarcoma of the breast by core needle biopsy. Front Med (Lausanne) Wu D, Li X, Tian X, Xu T, Ge Q, Luo S, Wang J. PMID: 41384108 [PubMed]
	Construction of a human epidermal growth factor receptor 2-related gene risk model for predicting breast cancer prognosis. Oncol Lett Huang L, Xu C, Song Y, Sun F, Sun X, Yao H, Liu M, Luo N. PMID: 41383978 [PubMed]
	Occult Breast Cancer Diagnosed from a Solitary Scalp Metastasis without Axillary Lymph Node Involvement: A Case Report. Surg Case Rep Ushio T, Teraoka S, Horimoto Y, Kusama H, Sugiyama Y, Ishikawa T, Kuroda M, Ikeda S. PMID: 41383821 [PubMed]
	Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation. Front Immunol Fan Y, Wang H, Zhang H, Ma T, Zhao Y. PMID: 41383624 [PubMed - indexed for MEDLINE]
	Post-Traumatic Growth in Young and Middle-Aged Breast Cancer Patients After Modified Radical Mastectomy: A Phenomenological Study. Psychol Res Behav Manag Gu Q, Hua H, Du L, Liu H. PMID: 41383487 [PubMed]
	Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in China: based on the SONIA trial. Front Pharmacol Jin X, Li Z. PMID: 41383485 [PubMed]
	Enhancing preoperative HER2 status classification of invasive breast cancers using machine learning models based on clinicopathological and MRI features: a multicenter study. Front Cell Dev Biol Zhao S, Li Z, Wang Y, Zhao F, Chen P, Pang G. PMID: 41383399 [PubMed]

Artikel 1 - 20 / 212644

Seite 1 von 10633

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung